
Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.
Highlights
The global Glaucoma Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Glaucoma Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Glaucoma Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Glaucoma Diagnostics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Glaucoma Diagnostics include NIDEK, Topcon Corporation, Heidelberg Engineering, Carl Zeiss Meditec, Optovue Incorporated, Leica Microsystems and Haag-Streit Group, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glaucoma Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma Diagnostics.
The Glaucoma Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Glaucoma Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glaucoma Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
NIDEK
Topcon Corporation
Heidelberg Engineering
Carl Zeiss Meditec
Optovue Incorporated
Leica Microsystems
Haag-Streit Group
Segment by Type
Open Angle Glaucoma
Low Tension Glaucoma
Pigmentary Glaucoma
Closed Angle Glaucoma
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glaucoma Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glaucoma Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Open Angle Glaucoma
1.2.3 Low Tension Glaucoma
1.2.4 Pigmentary Glaucoma
1.2.5 Closed Angle Glaucoma
1.2.6 Others
1.3 Market by Application
1.3.1 Global Glaucoma Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Glaucoma Diagnostics Market Perspective (2018-2029)
2.2 Glaucoma Diagnostics Growth Trends by Region
2.2.1 Global Glaucoma Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Glaucoma Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Glaucoma Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Glaucoma Diagnostics Market Dynamics
2.3.1 Glaucoma Diagnostics Industry Trends
2.3.2 Glaucoma Diagnostics Market Drivers
2.3.3 Glaucoma Diagnostics Market Challenges
2.3.4 Glaucoma Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glaucoma Diagnostics Players by Revenue
3.1.1 Global Top Glaucoma Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Glaucoma Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Glaucoma Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glaucoma Diagnostics Revenue
3.4 Global Glaucoma Diagnostics Market Concentration Ratio
3.4.1 Global Glaucoma Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glaucoma Diagnostics Revenue in 2022
3.5 Glaucoma Diagnostics Key Players Head office and Area Served
3.6 Key Players Glaucoma Diagnostics Product Solution and Service
3.7 Date of Enter into Glaucoma Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glaucoma Diagnostics Breakdown Data by Type
4.1 Global Glaucoma Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Glaucoma Diagnostics Forecasted Market Size by Type (2024-2029)
5 Glaucoma Diagnostics Breakdown Data by Application
5.1 Global Glaucoma Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Glaucoma Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Glaucoma Diagnostics Market Size (2018-2029)
6.2 North America Glaucoma Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Glaucoma Diagnostics Market Size by Country (2018-2023)
6.4 North America Glaucoma Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Glaucoma Diagnostics Market Size (2018-2029)
7.2 Europe Glaucoma Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Glaucoma Diagnostics Market Size by Country (2018-2023)
7.4 Europe Glaucoma Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glaucoma Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Glaucoma Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Glaucoma Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Glaucoma Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Glaucoma Diagnostics Market Size (2018-2029)
9.2 Latin America Glaucoma Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Glaucoma Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Glaucoma Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glaucoma Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Glaucoma Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Glaucoma Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Glaucoma Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NIDEK
11.1.1 NIDEK Company Detail
11.1.2 NIDEK Business Overview
11.1.3 NIDEK Glaucoma Diagnostics Introduction
11.1.4 NIDEK Revenue in Glaucoma Diagnostics Business (2018-2023)
11.1.5 NIDEK Recent Development
11.2 Topcon Corporation
11.2.1 Topcon Corporation Company Detail
11.2.2 Topcon Corporation Business Overview
11.2.3 Topcon Corporation Glaucoma Diagnostics Introduction
11.2.4 Topcon Corporation Revenue in Glaucoma Diagnostics Business (2018-2023)
11.2.5 Topcon Corporation Recent Development
11.3 Heidelberg Engineering
11.3.1 Heidelberg Engineering Company Detail
11.3.2 Heidelberg Engineering Business Overview
11.3.3 Heidelberg Engineering Glaucoma Diagnostics Introduction
11.3.4 Heidelberg Engineering Revenue in Glaucoma Diagnostics Business (2018-2023)
11.3.5 Heidelberg Engineering Recent Development
11.4 Carl Zeiss Meditec
11.4.1 Carl Zeiss Meditec Company Detail
11.4.2 Carl Zeiss Meditec Business Overview
11.4.3 Carl Zeiss Meditec Glaucoma Diagnostics Introduction
11.4.4 Carl Zeiss Meditec Revenue in Glaucoma Diagnostics Business (2018-2023)
11.4.5 Carl Zeiss Meditec Recent Development
11.5 Optovue Incorporated
11.5.1 Optovue Incorporated Company Detail
11.5.2 Optovue Incorporated Business Overview
11.5.3 Optovue Incorporated Glaucoma Diagnostics Introduction
11.5.4 Optovue Incorporated Revenue in Glaucoma Diagnostics Business (2018-2023)
11.5.5 Optovue Incorporated Recent Development
11.6 Leica Microsystems
11.6.1 Leica Microsystems Company Detail
11.6.2 Leica Microsystems Business Overview
11.6.3 Leica Microsystems Glaucoma Diagnostics Introduction
11.6.4 Leica Microsystems Revenue in Glaucoma Diagnostics Business (2018-2023)
11.6.5 Leica Microsystems Recent Development
11.7 Haag-Streit Group
11.7.1 Haag-Streit Group Company Detail
11.7.2 Haag-Streit Group Business Overview
11.7.3 Haag-Streit Group Glaucoma Diagnostics Introduction
11.7.4 Haag-Streit Group Revenue in Glaucoma Diagnostics Business (2018-2023)
11.7.5 Haag-Streit Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
NIDEK
Topcon Corporation
Heidelberg Engineering
Carl Zeiss Meditec
Optovue Incorporated
Leica Microsystems
Haag-Streit Group
Ìý
Ìý
*If Applicable.
